Zhuravlev Yelena, Hirsch Sophia M, Jordan Shawn N, Dumont Julien, Shirasu-Hiza Mimi, Canman Julie C
Department of Genetics and Development, Columbia University Medical Center, New York, NY 10032.
Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY 10032.
Mol Biol Cell. 2017 May 1;28(9):1258-1270. doi: 10.1091/mbc.E17-01-0020. Epub 2017 Mar 15.
Cytokinesis is driven by constriction of an actomyosin contractile ring that is controlled by Rho-family small GTPases. Rho, activated by the guanine-nucleotide exchange factor ECT-2, is upstream of both myosin-II activation and diaphanous formin-mediated filamentous actin (f-actin) assembly, which drive ring constriction. The role for Rac and its regulators is more controversial, but, based on the finding that Rac inactivation can rescue cytokinesis failure when the GTPase-activating protein (GAP) CYK-4 is disrupted, Rac activity was proposed to be inhibitory to contractile ring constriction and thus specifically inactivated by CYK-4 at the division plane. An alternative model proposes that Rac inactivation generally rescues cytokinesis failure by reducing cortical tension, thus making it easier for the cell to divide when ring constriction is compromised. In this alternative model, CYK-4 was instead proposed to activate Rho by binding ECT-2. Using a combination of time-lapse in vivo single-cell analysis and genetics, our evidence does not support this alternative model. First, we found that Rac disruption does not generally rescue cytokinesis failure: inhibition of Rac specifically rescues cytokinesis failure due to disruption of CYK-4 or ECT-2 but does not rescue cytokinesis failure due to disruption of two other contractile ring components, the Rho effectors diaphanous formin and myosin-II. Second, if CYK-4 regulates cytokinesis through Rho rather than Rac, then CYK-4 inhibition should decrease levels of downstream targets of Rho. Inconsistent with this, we found no change in the levels of f-actin or myosin-II at the division plane when CYK-4 GAP activity was reduced, suggesting that CYK-4 is not upstream of ECT-2/Rho activation. Instead, we found that the rescue of cytokinesis in CYK-4 mutants by Rac inactivation was Cdc42 dependent. Together our data suggest that CYK-4 GAP activity opposes Rac (and perhaps Cdc42) during cytokinesis.
胞质分裂由肌动球蛋白收缩环的收缩驱动,该收缩环受Rho家族小GTP酶控制。由鸟嘌呤核苷酸交换因子ECT - 2激活的Rho,位于肌球蛋白II激活和双盘状肌动蛋白介导的丝状肌动蛋白(f - 肌动蛋白)组装的上游,二者共同驱动环收缩。Rac及其调节因子的作用更具争议性,但是,基于当GTP酶激活蛋白(GAP)CYK - 4被破坏时Rac失活可挽救胞质分裂失败这一发现,有人提出Rac活性对收缩环收缩具有抑制作用,因此在分裂平面被CYK - 4特异性失活。另一种模型提出,Rac失活通常通过降低皮层张力来挽救胞质分裂失败,从而当环收缩受损时使细胞更容易分裂。在这个替代模型中,相反有人提出CYK - 4通过结合ECT - 2来激活Rho。通过体内延时单细胞分析和遗传学相结合的方法,我们的证据不支持这个替代模型。首先,我们发现Rac破坏一般不能挽救胞质分裂失败:抑制Rac可特异性挽救由于CYK - 4或ECT - 2破坏导致的胞质分裂失败,但不能挽救由于另外两个收缩环成分Rho效应器双盘状肌动蛋白和肌球蛋白II破坏导致的胞质分裂失败。其次,如果CYK - 4通过Rho而非Rac调节胞质分裂,那么抑制CYK - 4应该会降低Rho下游靶点的水平。与此不一致的是,当CYK - 4的GAP活性降低时,我们发现在分裂平面f - 肌动蛋白或肌球蛋白II的水平没有变化,这表明CYK - 4不在ECT - 2/Rho激活的上游。相反,我们发现Rac失活对CYK - 4突变体中胞质分裂的挽救作用是Cdc42依赖性的。我们的数据共同表明,CYK - 4的GAP活性在胞质分裂过程中对抗Rac(可能还有Cdc42)。